GPX4 and osteosarcoma: Notably, the upregulation of P53 expression leads to lower expression levels of SLC7A11 and GPX4, promoting the accumulation of ROS and the lipid peroxidation product malondialdehyde (MDA), which in turn induces ferroptosis in osteosarcoma.